These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Review article: new pharmacological agents for the treatment of gastro-oesophageal reflux disease. Vakil N Aliment Pharmacol Ther; 2004 May; 19(10):1041-9. PubMed ID: 15142193 [TBL] [Abstract][Full Text] [Related]
5. Medical treatment of GORD. Emerging therapeutic targets and concepts. Zerbib F Best Pract Res Clin Gastroenterol; 2010 Dec; 24(6):937-46. PubMed ID: 21126705 [TBL] [Abstract][Full Text] [Related]
6. Review article: the clinical relevance of transient lower oesophageal sphincter relaxations in gastro-oesophageal reflux disease. Kessing BF; Conchillo JM; Bredenoord AJ; Smout AJ; Masclee AA Aliment Pharmacol Ther; 2011 Mar; 33(6):650-61. PubMed ID: 21219371 [TBL] [Abstract][Full Text] [Related]
7. Review article: the pathophysiology of gastro-oesophageal reflux disease. Boeckxstaens GE Aliment Pharmacol Ther; 2007 Jul; 26(2):149-60. PubMed ID: 17593062 [TBL] [Abstract][Full Text] [Related]
8. Roles of gastro-oesophageal afferents in the mechanisms and symptoms of reflux disease. Page AJ; Blackshaw LA Handb Exp Pharmacol; 2009; (194):227-57. PubMed ID: 19655109 [TBL] [Abstract][Full Text] [Related]
9. Pathophysiology of gastro-oesophageal reflux disease. De Giorgi F; Palmiero M; Esposito I; Mosca F; Cuomo R Acta Otorhinolaryngol Ital; 2006 Oct; 26(5):241-6. PubMed ID: 17345925 [TBL] [Abstract][Full Text] [Related]
10. Update on drugs for gastro-oesophageal reflux disease. Keady S Arch Dis Child Educ Pract Ed; 2007 Aug; 92(4):ep114-8. PubMed ID: 17644666 [No Abstract] [Full Text] [Related]
11. Pathogenesis of gastro-oesophageal reflux disease and novel options for its therapy. Dent J Neurogastroenterol Motil; 2008 May; 20 Suppl 1():91-102. PubMed ID: 18402646 [TBL] [Abstract][Full Text] [Related]
12. [Prokinetics in reflux disease. Action mechanisms and clinical effects]. Hatlebakk JG; Berstad A Tidsskr Nor Laegeforen; 1994 Feb; 114(6):689-92. PubMed ID: 8191452 [TBL] [Abstract][Full Text] [Related]
13. Pathophysiological characteristics of the various forms of gastro-oesophageal reflux disease. Spectrum disease or distinct phenotypic presentations? Frazzoni M; Manno M; De Micheli E; Savarino V Dig Liver Dis; 2006 Sep; 38(9):643-8. PubMed ID: 16627016 [TBL] [Abstract][Full Text] [Related]
15. Managing gastro-oesophageal reflux in infants. Drug Ther Bull; 2009 Dec; 47(12):134-7. PubMed ID: 20009040 [TBL] [Abstract][Full Text] [Related]
16. Review article: the role of bile and pepsin in the pathophysiology and treatment of gastro-oesophageal reflux disease. Tack J Aliment Pharmacol Ther; 2006 Sep; 24 Suppl 2():10-6. PubMed ID: 16939428 [TBL] [Abstract][Full Text] [Related]
17. Rapid onset of effect of sodium alginate on gastro-oesophageal reflux compared with ranitidine and omeprazole, and relationship between symptoms and reflux episodes. Dettmar PW; Sykes J; Little SL; Bryan J Int J Clin Pract; 2006 Mar; 60(3):275-83. PubMed ID: 16494641 [TBL] [Abstract][Full Text] [Related]
18. Review article: role of pepsin and bile in gastro-oesophageal reflux disease. Tack J Aliment Pharmacol Ther; 2005 Aug; 22 Suppl 1():48-54. PubMed ID: 16042659 [TBL] [Abstract][Full Text] [Related]